Publication | Open Access

Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties

Fused HeterocyclesAntiviral ActivityMedicineImmunologyAntiviral Drug DevelopmentAntiviral TherapyPharmacological AgentPharmacotherapyAntiviral DrugHivPharmacologyAntiviral CompoundDrug DiscoveryPharmacokinetic Properties